Dopamine agonists mimic the action of dopamine at specific receptors in the brain but are not a first-line therapy for type 2 diabetes patients. Instead, they may be appropriate when other medications fail to adequately control an individual’s blood sugar level. A dopamine agonist may be prescribed alone or used in conjunction with a medication from another class such as a sulfonylurea or metformin. There is only one dopamine agonist approved for use in the treatment of type 2 diabetes. It is bromocriptine mesylate and sold under the brand name Cycloset.

Source: [Not Secure] www-dot-diabetesmonitor-dot-com/education-center/medications/dopamine-agonist.htm

Classes of Medications